Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aharonov

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|July 28, 2023
The new world of RNA diagnostics and therapeuticsGiovanni Blandino, Roberto Dinami, Marco Marcia, et al.
The Oncologist|May 24, 2012
A second-generation microRNA-based assay for diagnosing tumor tissue originEti Meiri, Wolf C Mueller, Shai Rosenwald, et al.
NPJ Precision Oncology|June 15, 2026
Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohortsChangsu L Park, Gal Dinstag, Carlos D Holanda Lopes, et al.
Nature|May 11, 2018
Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculationGonzalo Del Monte-Nieto, Mirana Ramialison, Arne A S Adam, et al.
Nature Cardiovascular Research|November 17, 2023
Redifferentiated cardiomyocytes retain residual dedifferentiation signatures and are protected against ischemic injuryAvraham Shakked, Zachary Petrover, Alla Aharonov, et al.
Research Square|June 5, 2026
SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancerAanika B Warner, Britanny B Solarz, Miroslava Belyov, et al.
Elife|December 24, 2019
Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heartHessel Honkoop, Dennis Em de Bakker, Alla Aharonov, et al.
Nature Biotechnology|March 26, 2008
MicroRNAs accurately identify cancer tissue originNitzan Rosenfeld, Ranit Aharonov, Eti Meiri, et al.
Research Square|October 4, 2023
Prediction of cancer treatment response from histopathology images through imputed transcriptomicsDanh-Tai Hoang, Gal Dinstag, Leandro C Hermida, et al.
Med (New York, N.Y.)|December 13, 2022
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeGal Dinstag, Eldad D Shulman, Efrat Elis, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Journal of Experimental & Clinical Cancer Research : CR|July 28, 2023
The new world of RNA diagnostics and therapeuticsGiovanni Blandino, Roberto Dinami, Marco Marcia, et al.
The Oncologist|May 24, 2012
A second-generation microRNA-based assay for diagnosing tumor tissue originEti Meiri, Wolf C Mueller, Shai Rosenwald, et al.
NPJ Precision Oncology|June 15, 2026
Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohortsChangsu L Park, Gal Dinstag, Carlos D Holanda Lopes, et al.
Nature|May 11, 2018
Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculationGonzalo Del Monte-Nieto, Mirana Ramialison, Arne A S Adam, et al.
Nature Cardiovascular Research|November 17, 2023
Redifferentiated cardiomyocytes retain residual dedifferentiation signatures and are protected against ischemic injuryAvraham Shakked, Zachary Petrover, Alla Aharonov, et al.
Research Square|June 5, 2026
SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancerAanika B Warner, Britanny B Solarz, Miroslava Belyov, et al.
Elife|December 24, 2019
Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heartHessel Honkoop, Dennis Em de Bakker, Alla Aharonov, et al.
Nature Biotechnology|March 26, 2008
MicroRNAs accurately identify cancer tissue originNitzan Rosenfeld, Ranit Aharonov, Eti Meiri, et al.
Research Square|October 4, 2023
Prediction of cancer treatment response from histopathology images through imputed transcriptomicsDanh-Tai Hoang, Gal Dinstag, Leandro C Hermida, et al.
Med (New York, N.Y.)|December 13, 2022
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeGal Dinstag, Eldad D Shulman, Efrat Elis, et al.
Pageof 18